US National Children's Hospital
New Treatment For Uroepithelial Carcinoma Receives Fda Fast Track Designation With Encouraging Initial Results
New Drug For IDH1 Mutation/Relapsed/Refractory Acute Myeloid Leukaemia With Good Complete Remission Rates And Manageable Toxicity
New York Presbyterian University Hospital of Columbia and Cornell
Frequent allergy in spring? Uncover the mystery of "allergy"!
Living cell anti-aging therapy is quietly emerging
